Bluefield Innovations
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
780 3rd Ave Fl 37 Th, New York City, New...Website
www.bluefieldinnovations.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Bluefield Innovations
Bluefield Innovations is a collaboration between Deerfield Management and Johns Hopkins University aimed at advancing early-stage therapeutics from concept to commercialization. With an initial funding of up to $65 million over five years, it supports the preclinical development process, including basic research and IND enabling studies. The partnership leverages Johns Hopkins' scientific expertise and Deerfield's financial and operational support to mitigate risks associated with novel projects. Their intended clients include researchers and innovators in the healthcare sector seeking to develop groundbreaking therapeutic solutions.Explore more
Popular SearchesBluefield Innovations LLCBluefield InnovationsSIC Code 87,873NAICS Code 54,541Show more
Bluefield Innovations Org Chart
SN
Associate Director, Technology Development, J...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bluefield Innovations your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Bluefield Innovations is spiking on competitors!
Click to see if Bluefield Innovations had a recent Job posting/layoffs
Product Launch: Get notified when Bluefield Innovations launches new products
Bluefield Innovations, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Bluefield Innovations has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Bluefield Innovations
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Bluefield Innovations has new funding data
Earning: See what the market has to say on Bluefield Innovations recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Bluefield Innovations
Compare insights from companies similar to Bluefield Innovations, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bluefield Innovations
<$5M
11-50
Private
-
2006
JP
Jeanine PenningtonDirector, Portfolio of Therapeutics & Diagnostic Licensing, Johns Hopkins Technology Ventures
<$5M
11-50
Private
-
-
SP
Suseelan PookoteDirector, Office of Technology Management, Uic (Joint Steering Committee)
Company Profile Activity
Activity Insights
Bluefield Innovations is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bluefield Innovations is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bluefield Innovations.
Bluefield Innovations Tech Stack
A closer look at the technologies used by Bluefield Innovations
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bluefield Innovations
Sign Up For FreeTo access detailed company insights
Bluefield Innovations is a collaboration between Deerfield Management and Johns Hopkins University aimed at advancing early-stage therapeutics from concept to commercialization. With an initial funding of up to $65 million over five years, it supports the preclinical development process, including basic research and IND enabling studies. The partne... Read More
